LIDOCAINE 4%

LIDOCAINE 4% was reported 55197 times

These side effects are most commonly reported by patients taking LIDOCAINE 4%:

# Side effect Count
0 DRUG INEFFECTIVE 4237
1 OFF LABEL USE 4118
2 PAIN 3465
3 PRODUCT ADHESION ISSUE 3439
4 PRODUCT QUALITY ISSUE 3191
5 FATIGUE 3190
6 NAUSEA 3183
7 HEADACHE 2936
8 DYSPNOEA 2272
9 PNEUMONIA 2080
10 DIARRHOEA 2059
11 SINUSITIS 1961
12 VOMITING 1936
13 FALL 1801
14 PRODUCT DOSE OMISSION ISSUE 1797
15 DIZZINESS 1796
16 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1767
17 DEATH 1755
18 PYREXIA 1684
19 HYPOTENSION 1656
20 URINARY TRACT INFECTION 1527
21 ANXIETY 1500
22 RASH 1454
23 ARTHRALGIA 1416
24 MALAISE 1413
25 COVID-19 1404
26 BACK PAIN 1397
27 COUGH 1368
28 ASTHENIA 1296
29 TOXICITY TO VARIOUS AGENTS 1273
30 PRODUCT USE IN UNAPPROVED INDICATION 1245
31 PAIN IN EXTREMITY 1218
32 RENAL FAILURE 1199
33 WEIGHT DECREASED 1195
34 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1137
35 PRURITUS 1135
36 NASOPHARYNGITIS 1096
37 HYPERTENSION 1039
38 CONSTIPATION 1015
39 CARDIAC ARREST 998
40 CONDITION AGGRAVATED 931
41 ACUTE KIDNEY INJURY 928
42 DECREASED APPETITE 879
43 SOMNOLENCE 875
44 BRONCHITIS 864
45 ABDOMINAL PAIN 855
46 CHRONIC KIDNEY DISEASE 843
47 ILLNESS 838
48 INFECTION 834
49 INSOMNIA 825
50 DEPRESSION 822
51 ANAPHYLACTIC REACTION 809
52 CHEST PAIN 809
53 ANAEMIA 807
54 DRUG HYPERSENSITIVITY 807
55 DRUG INTERACTION 803
56 UPPER RESPIRATORY TRACT INFECTION 771
57 BLOOD PRESSURE INCREASED 762
58 PRODUCT USE ISSUE 758
59 SEPSIS 754
60 ERYTHEMA 745
61 CONFUSIONAL STATE 716
62 INFLUENZA 716
63 MUSCLE SPASMS 714
64 WEIGHT INCREASED 711
65 FEELING ABNORMAL 704
66 GAIT DISTURBANCE 687
67 TACHYCARDIA 687
68 PERIPHERAL SWELLING 686
69 HYPOAESTHESIA 683
70 LOSS OF CONSCIOUSNESS 677
71 SEIZURE 675
72 TREMOR 674
73 CHILLS 664
74 HYPERSENSITIVITY 660
75 INFUSION RELATED REACTION 658
76 URTICARIA 641
77 OVERDOSE 638
78 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 633
79 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 628
80 INJECTION SITE PAIN 627
81 INJURY 625
82 MIGRAINE 616
83 DEHYDRATION 612
84 NO ADVERSE EVENT 612
85 BRADYCARDIA 608
86 STRESS 608
87 PARAESTHESIA 606
88 CONTUSION 605
89 EMOTIONAL DISTRESS 595
90 ABDOMINAL PAIN UPPER 576
91 INFUSION SITE PAIN 549
92 UNEVALUABLE EVENT 545
93 INSURANCE ISSUE 535
94 ATRIAL FIBRILLATION 534
95 SWELLING 525
96 ANAPHYLACTIC SHOCK 522
97 EAR INFECTION 522
98 OEDEMA PERIPHERAL 513
99 FEBRILE NEUTROPENIA 505
100 RESPIRATORY TRACT INFECTION 505
101 MYALGIA 500
102 MUSCULAR WEAKNESS 493
103 OROPHARYNGEAL PAIN 489
104 ASTHMA 487
105 ALOPECIA 484
106 ABDOMINAL DISCOMFORT 482
107 ABDOMINAL DISTENSION 475
108 HYPERHIDROSIS 474
109 NEUROPATHY PERIPHERAL 473
110 RESPIRATORY FAILURE 460
111 CEREBROVASCULAR ACCIDENT 458
112 HEART RATE INCREASED 453
113 VISION BLURRED 453
114 INTENTIONAL PRODUCT USE ISSUE 444
115 CELLULITIS 440
116 CHEST DISCOMFORT 440
117 GASTROOESOPHAGEAL REFLUX DISEASE 434
118 HYPOXIA 432
119 RENAL INJURY 429
120 MEMORY IMPAIRMENT 421
121 INCORRECT DOSE ADMINISTERED 419
122 SEASONAL ALLERGY 419
123 SYNCOPE 418
124 BLOOD PRESSURE DECREASED 415
125 OXYGEN SATURATION DECREASED 412
126 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 406
127 GASTROINTESTINAL DISORDER 404
128 DYSPHAGIA 402
129 MATERNAL EXPOSURE DURING PREGNANCY 396
130 PRODUCTIVE COUGH 396
131 NECK PAIN 394
132 PALPITATIONS 394
133 PULMONARY EMBOLISM 394
134 ANHEDONIA 392
135 PLEURAL EFFUSION 387
136 RENAL IMPAIRMENT 384
137 END STAGE RENAL DISEASE 379
138 DRUG INTOLERANCE 378
139 HERPES ZOSTER 377
140 INFUSION SITE SWELLING 375
141 NEUTROPENIA 372
142 INFUSION SITE ERYTHEMA 366
143 VIRAL INFECTION 361
144 HOSPITALISATION 360
145 FEAR 358
146 THROMBOSIS 357
147 JOINT SWELLING 356
148 VENTRICULAR TACHYCARDIA 356
149 INFLUENZA LIKE ILLNESS 355
150 DRY MOUTH 353
151 ARTHRITIS 349
152 GENERAL PHYSICAL HEALTH DETERIORATION 349
153 OEDEMA 348
154 HAEMOGLOBIN DECREASED 341
155 MUSCULOSKELETAL STIFFNESS 338
156 VISUAL IMPAIRMENT 338
157 THROMBOCYTOPENIA 337
158 STAPHYLOCOCCAL INFECTION 336
159 BALANCE DISORDER 333
160 PLATELET COUNT DECREASED 323
161 EPISTAXIS 322
162 INTENTIONAL PRODUCT MISUSE 318
163 UNRESPONSIVE TO STIMULI 315
164 BURNING SENSATION 313
165 MYOCARDIAL INFARCTION 311
166 AGITATION 309
167 HAEMORRHAGE 308
168 CYSTITIS 307
169 LETHARGY 307
170 STOMATITIS 306
171 DISCOMFORT 302
172 SLEEP DISORDER 302
173 FLUSHING 301
174 CATARACT 300
175 MENTAL STATUS CHANGES 296
176 WHITE BLOOD CELL COUNT DECREASED 296
177 DYSPEPSIA 295
178 MULTIPLE ALLERGIES 295
179 THERAPY NON-RESPONDER 295
180 GENERALISED TONIC-CLONIC SEIZURE 293
181 PULMONARY OEDEMA 293
182 RHEUMATOID ARTHRITIS 292
183 CARDIAC DISORDER 290
184 EXPOSURE DURING PREGNANCY 289
185 BLOOD GLUCOSE INCREASED 285
186 DERMATITIS CONTACT 285
187 HYPONATRAEMIA 285
188 NASAL CONGESTION 284
189 DISEASE PROGRESSION 283
190 NEURALGIA 279
191 VENTRICULAR FIBRILLATION 279
192 DRUG ABUSE 278
193 WHEEZING 278
194 NEPHROLITHIASIS 275
195 DIABETES MELLITUS 271
196 DYSARTHRIA 264
197 TREATMENT FAILURE 263
198 CARDIO-RESPIRATORY ARREST 260
199 INFUSION SITE PRURITUS 257
200 RHINORRHOEA 257
201 VERTIGO 257
202 CARDIAC FAILURE CONGESTIVE 256
203 SWELLING FACE 252
204 METHAEMOGLOBINAEMIA 251
205 GASTROENTERITIS VIRAL 250
206 HALLUCINATION 250
207 CARDIOGENIC SHOCK 249
208 HYPOKALAEMIA 249
209 INFUSION SITE EXTRAVASATION 249
210 INJECTION SITE ERYTHEMA 249
211 DRY SKIN 248
212 EYE PAIN 245
213 LOWER RESPIRATORY TRACT INFECTION 245
214 OSTEOARTHRITIS 245
215 DYSPHONIA 243
216 DEEP VEIN THROMBOSIS 242
217 INFUSION SITE HAEMORRHAGE 241
218 MULTI-ORGAN FAILURE 238
219 OSTEOPOROSIS 238
220 MALIGNANT NEOPLASM PROGRESSION 234
221 LOCALISED INFECTION 233
222 ADVERSE DRUG REACTION 232
223 CARDIAC FAILURE 232
224 MOBILITY DECREASED 232
225 COMA 231
226 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 231
227 RENAL FAILURE ACUTE 230
228 SUICIDAL IDEATION 230
229 LIMB INJURY 227
230 BLISTER 226
231 FLUID RETENTION 226
232 MUSCULOSKELETAL PAIN 226
233 BACTERIAL INFECTION 225
234 FUNGAL INFECTION 225
235 DEPRESSED LEVEL OF CONSCIOUSNESS 224
236 SPEECH DISORDER 224
237 TINNITUS 224
238 DELIRIUM 222
239 SINUS DISORDER 222
240 SURGERY 222
241 DYSPNOEA EXERTIONAL 220
242 INFUSION SITE DISCHARGE 220
243 KIDNEY INFECTION 219
244 AMNESIA 218
245 MULTIPLE ORGAN DYSFUNCTION SYNDROME 218
246 FOETAL EXPOSURE DURING PREGNANCY 217
247 GASTROINTESTINAL HAEMORRHAGE 215
248 BLOOD CREATININE INCREASED 212
249 NEPHROGENIC ANAEMIA 212
250 SINUS TACHYCARDIA 212
251 ELECTROCARDIOGRAM QT PROLONGED 211
252 BLOOD CHOLESTEROL INCREASED 209
253 FIBROMYALGIA 208
254 POOR VENOUS ACCESS 205
255 ROAD TRAFFIC ACCIDENT 205
256 POST PROCEDURAL COMPLICATION 204
257 SEPTIC SHOCK 204
258 ANGIOEDEMA 203
259 BONE PAIN 203
260 MEDICATION ERROR 203
261 ARTHROPATHY 200
262 HOT FLUSH 200
263 SKIN DISCOLOURATION 200
264 ARRHYTHMIA 199
265 LUNG DISORDER 199
266 RESPIRATORY DISTRESS 198
267 NEUROTOXICITY 197
268 PANCYTOPENIA 196
269 STATUS EPILEPTICUS 196
270 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 195
271 DIPLOPIA 194
272 THERAPY INTERRUPTED 193
273 RIB FRACTURE 192
274 APPLICATION SITE PAIN 190
275 ASPARTATE AMINOTRANSFERASE INCREASED 190
276 METABOLIC ACIDOSIS 189
277 ALANINE AMINOTRANSFERASE INCREASED 188
278 CONVULSION 188
279 HEART RATE DECREASED 188
280 RASH PRURITIC 188
281 SKIN EXFOLIATION 188
282 FEELING HOT 184
283 ACCIDENTAL OVERDOSE 183
284 DYSGEUSIA 182
285 INJECTION SITE SWELLING 182
286 INFUSION SITE BRUISING 180
287 DIVERTICULITIS 178
288 INCORRECT DRUG ADMINISTRATION RATE 178
289 ASCITES 177
290 EXPIRED PRODUCT ADMINISTERED 177
291 TOXIC ANTERIOR SEGMENT SYNDROME 177
292 ACUTE RESPIRATORY FAILURE 176
293 LYMPHADENOPATHY 175
294 DRUG DOSE OMISSION 174
295 HEAD INJURY 174
296 MENTAL DISORDER 174
297 CANDIDA INFECTION 173
298 RESPIRATORY ARREST 173
299 ACCIDENTAL EXPOSURE TO PRODUCT 172
300 DRUG DEPENDENCE 172
301 ENCEPHALOPATHY 172
302 PRODUCT AVAILABILITY ISSUE 172
303 CIRCULATORY COLLAPSE 171
304 COGNITIVE DISORDER 171
305 PREMATURE BABY 171
306 HYPERKALAEMIA 170
307 INFLAMMATION 168
308 RESPIRATORY DISORDER 168
309 URINARY RETENTION 168
310 RESTLESSNESS 167
311 APPLICATION SITE ERYTHEMA 166
312 DISTURBANCE IN ATTENTION 166
313 PROCEDURAL PAIN 166
314 DYSKINESIA 165
315 DYSURIA 165
316 SKIN INFECTION 165
317 HAEMORRHOIDS 164
318 PNEUMONIA ASPIRATION 164
319 TOOTH INFECTION 164
320 NERVOUSNESS 161
321 PRODUCT DISTRIBUTION ISSUE 161
322 WHITE BLOOD CELL COUNT INCREASED 161
323 COLITIS 160
324 BLINDNESS 159
325 BLOOD POTASSIUM DECREASED 159
326 INTERVERTEBRAL DISC PROTRUSION 159
327 PAIN IN JAW 159
328 MATERNAL EXPOSURE DURING DELIVERY 158
329 THROAT IRRITATION 158
330 ANAESTHETIC COMPLICATION 157
331 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 157
332 DRY EYE 156
333 DISORIENTATION 155
334 FLATULENCE 155
335 SKIN ULCER 155
336 DEVICE ISSUE 154
337 INTENTIONAL OVERDOSE 154
338 RECTAL HAEMORRHAGE 154
339 RENAL DISORDER 154
340 RESPIRATORY DEPRESSION 154
341 PSORIASIS 153
342 URINARY INCONTINENCE 153
343 LIMB DISCOMFORT 152
344 FOOT FRACTURE 150
345 ADVERSE EVENT 149
346 BRONCHOSPASM 148
347 HYPOAESTHESIA ORAL 148
348 INJECTION SITE BRUISING 146
349 SLEEP APNOEA SYNDROME 146
350 VISUAL ACUITY REDUCED 146
351 NEOPLASM MALIGNANT 145
352 PHARYNGITIS STREPTOCOCCAL 145
353 BODY TEMPERATURE INCREASED 144
354 HEPATIC ENZYME INCREASED 144
355 SCAR 144
356 SHOCK 144
357 HYPOTHYROIDISM 143
358 SCIATICA 142
359 TENDERNESS 142
360 OSTEOMYELITIS 141
361 CLOSTRIDIUM DIFFICILE INFECTION 140
362 IMPAIRED HEALING 140
363 SKIN DISORDER 140
364 BRAIN OEDEMA 139
365 INJECTION SITE PRURITUS 139
366 LIP SWELLING 139
367 ORAL PAIN 139
368 JOINT INJURY 138
369 MYDRIASIS 138
370 POOR QUALITY SLEEP 138
371 SKIN LACERATION 138
372 SWOLLEN TONGUE 138
373 HAEMOPTYSIS 137
374 RASH ERYTHEMATOUS 137
375 APHASIA 136
376 POLLAKIURIA 136
377 PALLOR 135
378 VENTRICULAR EXTRASYSTOLES 135
379 CROHN^S DISEASE 134
380 ECONOMIC PROBLEM 134
381 HYPERLIPIDAEMIA 134
382 NERVOUS SYSTEM DISORDER 134
383 APPLICATION SITE RASH 133
384 EYE IRRITATION 133
385 NIGHT SWEATS 133
386 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 133
387 THERAPEUTIC RESPONSE DECREASED 133
388 ATELECTASIS 132
389 COMPLETED SUICIDE 132
390 DRUG LEVEL INCREASED 132
391 SEROTONIN SYNDROME 132
392 STRESS CARDIOMYOPATHY 132
393 GAIT INABILITY 131
394 HAEMATOMA 131
395 C-REACTIVE PROTEIN INCREASED 130
396 DRUG EFFECT DECREASED 130
397 MYASTHENIA GRAVIS 130
398 MUSCULOSKELETAL CHEST PAIN 129
399 GOUT 128
400 PRODUCT DOSE OMISSION 128
401 WOUND 128
402 BLOOD PRESSURE ABNORMAL 127
403 CHOLELITHIASIS 127
404 INTESTINAL OBSTRUCTION 127
405 RESPIRATORY TRACT CONGESTION 127
406 APNOEA 126
407 APPENDICITIS 126
408 HAEMATURIA 126
409 HYPOPHOSPHATAEMIA 125
410 PHARYNGITIS 125
411 RED BLOOD CELL COUNT DECREASED 125
412 HAEMATOCHEZIA 124
413 INJECTION SITE REACTION 124
414 MUCOSAL INFLAMMATION 124
415 TRANSIENT ISCHAEMIC ATTACK 124
416 HAEMODYNAMIC INSTABILITY 123
417 MUSCLE TWITCHING 123
418 NEEDLE ISSUE 123
419 PULMONARY HYPERTENSION 123
420 THERAPEUTIC RESPONSE UNEXPECTED 123
421 TOOTH DISORDER 123
422 ACUTE MYOCARDIAL INFARCTION 122
423 CYTOKINE RELEASE SYNDROME 122
424 HAEMATOCRIT DECREASED 122
425 PRODUCT SUBSTITUTION ISSUE 122
426 PULSELESS ELECTRICAL ACTIVITY 122
427 SPINAL FRACTURE 122
428 THERAPY PARTIAL RESPONDER 122
429 APPLICATION SITE PRURITUS 121
430 OCULAR HYPERAEMIA 121
431 EYE INFECTION 120
432 INTERVERTEBRAL DISC DEGENERATION 120
433 EAR PAIN 119
434 IRRITABILITY 119
435 MYOCLONUS 119
436 HIP FRACTURE 118
437 CYANOSIS 117
438 ILL-DEFINED DISORDER 117
439 IMPAIRED GASTRIC EMPTYING 117
440 NEUTROPHIL COUNT DECREASED 117
441 ULCER 117
442 DRUG WITHDRAWAL SYNDROME 116
443 DYSSTASIA 116
444 PRESYNCOPE 116
445 SPINAL OSTEOARTHRITIS 116
446 BONE DENSITY DECREASED 114
447 DEPRESSED MOOD 114
448 DISABILITY 114
449 MUSCULOSKELETAL DISCOMFORT 114
450 PNEUMOTHORAX 114
451 ECZEMA 113
452 FEELING COLD 113
453 LIVER DISORDER 113
454 PLASMA CELL MYELOMA 113
455 ROTATOR CUFF SYNDROME 113
456 SINUS BRADYCARDIA 113
457 INCORRECT PRODUCT ADMINISTRATION DURATION 112
458 IRRITABLE BOWEL SYNDROME 112
459 OSTEOPENIA 112
460 THERAPEUTIC PRODUCT EFFECT DECREASED 112
461 BLOOD GLUCOSE DECREASED 111
462 HYPERPARATHYROIDISM SECONDARY 111
463 HYPOACUSIS 111
464 SKIN IRRITATION 111
465 KOUNIS SYNDROME 110
466 TACHYPNOEA 110
467 TREATMENT NONCOMPLIANCE 110
468 WEIGHT FLUCTUATION 110
469 DEVICE INFUSION ISSUE 109
470 HYPERSOMNIA 109
471 PREMATURE DELIVERY 109
472 SKIN LESION 109
473 CORONARY ARTERY DISEASE 108
474 GASTROINTESTINAL INFECTION 108
475 ORAL CANDIDIASIS 108
476 ORAL HERPES 108
477 APPLICATION SITE IRRITATION 107
478 CONJUNCTIVITIS 107
479 PARAESTHESIA ORAL 107
480 HYPOGLYCAEMIA 106
481 LEUKOCYTOSIS 106
482 BRAIN FOG 105
483 HIATUS HERNIA 105
484 PANCREATITIS 105
485 UPPER LIMB FRACTURE 105
486 CARPAL TUNNEL SYNDROME 104
487 INCORRECT ROUTE OF DRUG ADMINISTRATION 104
488 PRODUCT DOSE OMISSION IN ERROR 104
489 TOOTH ABSCESS 104
490 INTENTIONAL DOSE OMISSION 103
491 NERVE INJURY 103
492 TOOTHACHE 103
493 CHROMATURIA 102
494 GASTRITIS 102
495 HALLUCINATION, VISUAL 102
496 PANIC ATTACK 102
497 LIVE BIRTH 101
498 TUBULOINTERSTITIAL NEPHRITIS 101
499 HORNER^S SYNDROME 100
500 MASS 100
501 SINUS CONGESTION 100
502 THROAT TIGHTNESS 100
503 COVID-19 PNEUMONIA 99
504 HEART RATE IRREGULAR 99
505 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 99
506 LACRIMATION INCREASED 99
507 LIVER FUNCTION TEST INCREASED 99
508 PULMONARY MASS 99
509 RASH MACULAR 99
510 BACK DISORDER 98
511 BLOOD PRESSURE FLUCTUATION 98
512 BODY HEIGHT DECREASED 98
513 IMPAIRED QUALITY OF LIFE 98
514 INFUSION SITE MASS 98
515 DRUG TOXICITY 97
516 INJECTION SITE HAEMORRHAGE 97
517 RESPIRATORY SYNCYTIAL VIRUS INFECTION 97
518 SPINAL OPERATION 97
519 WITHDRAWAL SYNDROME 97
520 AGGRESSION 96
521 LEUKOPENIA 96
522 PRODUCT ADMINISTRATION INTERRUPTED 96
523 PULSE ABSENT 96
524 SEDATION 96
525 ANKLE FRACTURE 95
526 HYPERPHOSPHATAEMIA 95
527 MULTIPLE SCLEROSIS RELAPSE 95
528 OSTEONECROSIS 95
529 SYSTEMIC LUPUS ERYTHEMATOSUS 95
530 DECUBITUS ULCER 94
531 DEVICE DISLOCATION 94
532 IRON DEFICIENCY 94
533 PSEUDOMONAS INFECTION 94
534 CEREBRAL HAEMORRHAGE 93
535 RHABDOMYOLYSIS 93
536 BLOOD PHOSPHORUS INCREASED 92
537 BONE DISORDER 92
538 CRYING 92
539 HYPERGLYCAEMIA 92
540 MOUTH ULCERATION 92
541 PERICARDIAL EFFUSION 92
542 PHOTOPHOBIA 92
543 SPINAL PAIN 92
544 HEMIPARESIS 91
545 INFUSION SITE REACTION 91
546 OBSTRUCTION 91
547 PNEUMONITIS 91
548 BLOOD BILIRUBIN INCREASED 90
549 BRONCHIECTASIS 90
550 EATING DISORDER 90
551 EYE DISORDER 90
552 PSORIATIC ARTHROPATHY 90
553 APPENDICOLITH 89
554 BLOOD URIC ACID INCREASED 89
555 CARDIOMEGALY 89
556 HERNIA 89
557 ABSCESS 88
558 BLOOD UREA INCREASED 88
559 BLOOD URINE PRESENT 88
560 EYE SWELLING 88
561 INSPIRATORY CAPACITY DECREASED 88
562 JOINT STIFFNESS 88
563 PARALYSIS 88
564 SENSORY LOSS 88
565 SUICIDE ATTEMPT 88
566 BLOOD ALKALINE PHOSPHATASE INCREASED 87
567 BLOOD SODIUM DECREASED 87
568 DEAFNESS 87
569 DEVICE RELATED INFECTION 87
570 LOWER LIMB FRACTURE 87
571 POST PROCEDURAL INFECTION 87
572 RESTLESS LEGS SYNDROME 87
573 RETCHING 87
574 EJECTION FRACTION DECREASED 86
575 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 86
576 LIGAMENT SPRAIN 86
577 MENTAL IMPAIRMENT 86
578 MOVEMENT DISORDER 86
579 MULTIPLE SCLEROSIS 86
580 PROCTALGIA 86
581 RENAL TUBULAR NECROSIS 86
582 SMALL INTESTINAL OBSTRUCTION 86
583 STREPTOCOCCAL INFECTION 86
584 TASTE DISORDER 86
585 TORSADE DE POINTES 86
586 TROPONIN INCREASED 86
587 BREAST CANCER 85
588 BURSITIS 85
589 COLD SWEAT 85
590 LYMPHOCYTE COUNT DECREASED 85
591 MUSCLE TIGHTNESS 85
592 PULMONARY CONGESTION 85
593 SNEEZING 85
594 CARDIOTOXICITY 84
595 CLOSTRIDIUM DIFFICILE COLITIS 84
596 DYSTONIA 84
597 INABILITY TO AFFORD MEDICATION 84
598 INFUSION SITE RASH 84
599 NEOPLASM PROGRESSION 84
600 SUPRAVENTRICULAR TACHYCARDIA 84
601 HYPOPHAGIA 83
602 ALTERED STATE OF CONSCIOUSNESS 82
603 INJECTION SITE MASS 82
604 SKIN BURNING SENSATION 82
605 ANGINA PECTORIS 81
606 APHONIA 81
607 GLAUCOMA 81
608 GASTRIC DISORDER 80
609 LARYNGITIS 80
610 OBSTRUCTIVE AIRWAYS DISORDER 80
611 PRODUCT ADMINISTRATION ERROR 80
612 THERAPY CESSATION 80
613 DEVICE MALFUNCTION 79
614 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 79
615 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 79
616 HEPATIC FAILURE 79
617 PRODUCT STORAGE ERROR 79
618 APPLICATION SITE DISCOMFORT 78
619 ASPIRATION 78
620 BACTERAEMIA 78
621 JOINT RANGE OF MOTION DECREASED 78
622 PROCEDURAL COMPLICATION 78
623 PRODUCT PRESCRIBING ISSUE 78
624 REBOUND ACID HYPERSECRETION 78
625 ACUTE RESPIRATORY DISTRESS SYNDROME 77
626 CONCUSSION 77
627 ENDOPHTHALMITIS 77
628 GRAND MAL CONVULSION 77
629 INCONTINENCE 77
630 NERVE COMPRESSION 77
631 RASH MACULO-PAPULAR 77
632 SKIN ABRASION 77
633 VITREOUS FLOATERS 77
634 ACCIDENT 76
635 BLOOD PRESSURE SYSTOLIC INCREASED 76
636 CARDIOMYOPATHY 76
637 COAGULOPATHY 76
638 ESCHERICHIA INFECTION 76
639 NODULE 76
640 OSTEONECROSIS OF JAW 76
641 TYPE 2 DIABETES MELLITUS 76
642 BASAL CELL CARCINOMA 75
643 DERMATITIS 75
644 EXOSTOSIS 75
645 EYELID PTOSIS 75
646 FACIAL PAIN 75
647 FEEDING DISORDER 75
648 HEREDITARY ANGIOEDEMA 75
649 MALNUTRITION 75
650 DRUG EFFECT INCOMPLETE 74
651 EMOTIONAL DISORDER 74
652 FULL BLOOD COUNT DECREASED 74
653 INTERSTITIAL LUNG DISEASE 74
654 IRON DEFICIENCY ANAEMIA 74
655 JOINT DISLOCATION 74
656 PULMONARY FIBROSIS 74
657 WOUND INFECTION 74
658 ACNE 73
659 GALLBLADDER DISORDER 73
660 HEPATIC STEATOSIS 73
661 HYPERAESTHESIA 73
662 MUSCLE STRAIN 73
663 VASCULAR DEVICE INFECTION 73
664 AUTOIMMUNE DISORDER 72
665 EPILEPSY 72
666 INTERNATIONAL NORMALISED RATIO INCREASED 72
667 SKIN CANCER 72
668 VAGINAL HAEMORRHAGE 72
669 ATAXIA 71
670 CHRONIC SINUSITIS 71
671 HYPOMAGNESAEMIA 71
672 TOXIC EPIDERMAL NECROLYSIS 71
673 VITAMIN D DEFICIENCY 71
674 FOOD ALLERGY 70
675 INADEQUATE ANALGESIA 70
676 LACTIC ACIDOSIS 70
677 PRODUCT PREPARATION ERROR 70
678 STEVENS-JOHNSON SYNDROME 70
679 ANAL INCONTINENCE 69
680 DEVICE LEAKAGE 69
681 FACIAL PARALYSIS 69
682 HAEMATEMESIS 69
683 HEAD DISCOMFORT 69
684 NIGHTMARE 69
685 PREGNANCY 69
686 THERAPEUTIC RESPONSE SHORTENED 69
687 ARTHROPOD BITE 68
688 BACK INJURY 68
689 BLOOD TEST ABNORMAL 68
690 CORNEAL OEDEMA 68
691 DEMENTIA 68
692 FLANK PAIN 68
693 MICTURITION URGENCY 68
694 MIOSIS 68
695 MITRAL VALVE INCOMPETENCE 68
696 DISSEMINATED INTRAVASCULAR COAGULATION 67
697 FACE OEDEMA 67
698 HEPATIC FUNCTION ABNORMAL 67
699 INCORRECT DRUG ADMINISTRATION DURATION 67
700 RASH PAPULAR 67
701 WRONG TECHNIQUE IN DRUG USAGE PROCESS 67
702 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 66
703 ACTIVITIES OF DAILY LIVING IMPAIRED 66
704 BLOOD POTASSIUM INCREASED 66
705 ILEUS 66
706 IMPAIRED WORK ABILITY 66
707 LEFT VENTRICULAR DYSFUNCTION 66
708 MUSCLE RIGIDITY 66
709 UNDERDOSE 66
710 AGEUSIA 65
711 COMPLICATION ASSOCIATED WITH DEVICE 65
712 MENINGITIS 65
713 MOTOR DYSFUNCTION 65
714 PRE-EXISTING CONDITION IMPROVED 65
715 PRODUCT PHYSICAL ISSUE 65
716 SPINAL DISORDER 65
717 TENDONITIS 65
718 TOOTH LOSS 65
719 UPPER-AIRWAY COUGH SYNDROME 65
720 WRIST FRACTURE 65
721 BRAIN INJURY 64
722 BUNDLE BRANCH BLOCK LEFT 64
723 HYPERCHOLESTEROLAEMIA 64
724 NYSTAGMUS 64
725 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 64
726 PHARYNGEAL SWELLING 64
727 PSYCHOTIC DISORDER 64
728 TYPE I HYPERSENSITIVITY 64
729 BLOOD IRON DECREASED 63
730 CYST 63
731 DENTAL CARIES 63
732 DEVICE DIFFICULT TO USE 63
733 EYE PRURITUS 63
734 GASTRIC ULCER 63
735 GLUCOSE TOLERANCE IMPAIRED 63
736 PNEUMONIA BACTERIAL 63
737 QUALITY OF LIFE DECREASED 63
738 BLOOD CALCIUM INCREASED 62
739 BLOOD CREATINE PHOSPHOKINASE INCREASED 62
740 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 62
741 LUNG INFECTION 62
742 PERICARDITIS 62
743 RENAL CYST 62
744 RHINOVIRUS INFECTION 62
745 ABNORMAL BEHAVIOUR 61
746 ANALGESIC THERAPY 61
747 AORTIC STENOSIS 61
748 ARTHRITIS BACTERIAL 61
749 DISEASE RECURRENCE 61
750 DRUG THERAPY 61
751 ELECTROLYTE IMBALANCE 61
752 GENERALISED OEDEMA 61
753 LABORATORY TEST ABNORMAL 61
754 MENINGITIS ASEPTIC 61
755 PARAPLEGIA 61
756 PHOTOSENSITIVITY REACTION 61
757 SLEEP DISORDER THERAPY 61
758 SPINAL COMPRESSION FRACTURE 61
759 THYROID DISORDER 61
760 VASOPLEGIA SYNDROME 61
761 ATRIOVENTRICULAR BLOCK COMPLETE 60
762 EMPHYSEMA 60
763 HOSPICE CARE 60
764 INFUSION SITE URTICARIA 60
765 KNEE ARTHROPLASTY 60
766 NEPHROPATHY 60
767 SPUTUM DISCOLOURED 60
768 BLADDER DISORDER 59
769 DERMATITIS ALLERGIC 59
770 DRUG ADMINISTRATION ERROR 59
771 INFUSION SITE WARMTH 59
772 MYOCARDIAL ISCHAEMIA 59
773 POST PROCEDURAL HAEMORRHAGE 59
774 TRANSAMINASES INCREASED 59
775 ABDOMINAL PAIN LOWER 58
776 DEVICE OCCLUSION 58
777 HYPERTHERMIA MALIGNANT 58
778 INFUSION SITE DISCOMFORT 58
779 LYMPHOEDEMA 58
780 OBESITY 58
781 BLOOD TRIGLYCERIDES INCREASED 57
782 DERMATITIS ATOPIC 57
783 FOOT DEFORMITY 57
784 HYPERTENSIVE CRISIS 57
785 HYPOKINESIA 57
786 INFUSION SITE IRRITATION 57
787 INTRAOCULAR PRESSURE INCREASED 57
788 LUNG INFILTRATION 57
789 LUNG OPACITY 57
790 MOOD ALTERED 57
791 PULMONARY THROMBOSIS 57
792 RALES 57
793 UROSEPSIS 57
794 BLOOD CALCIUM DECREASED 56
795 BREATH SOUNDS ABNORMAL 56
796 HEPATIC CIRRHOSIS 56
797 NORMAL NEWBORN 56
798 VENTRICULAR HYPOKINESIA 56
799 ECCHYMOSIS 55
800 EXTRA DOSE ADMINISTERED 55
801 FOOD POISONING 55
802 GLOSSODYNIA 55
803 HIP ARTHROPLASTY 55
804 METASTASES TO BONE 55
805 OTITIS MEDIA 55
806 PARANOIA 55
807 PARKINSON^S DISEASE 55
808 PRODUCT USE COMPLAINT 55
809 SARS-COV-2 TEST POSITIVE 55
810 SENSITIVE SKIN 55
811 VENTRICULAR ARRHYTHMIA 55
812 ARTHRITIS INFECTIVE 54
813 CONTRAINDICATED PRODUCT ADMINISTERED 54
814 DRUG EFFECT LESS THAN EXPECTED 54
815 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 54
816 OESOPHAGITIS 54
817 ORTHOSTATIC HYPOTENSION 54
818 PERIPHERAL VASCULAR DISORDER 54
819 POSTOPERATIVE WOUND INFECTION 54
820 SKIN REACTION 54
821 TOOTH FRACTURE 54
822 ANAESTHETIC COMPLICATION NEUROLOGICAL 53
823 DIZZINESS POSTURAL 53
824 FEMUR FRACTURE 53
825 HAND FRACTURE 53
826 OCULAR DISCOMFORT 53
827 PULMONARY ARTERIAL HYPERTENSION 53
828 RESPIRATORY TRACT INFECTION VIRAL 53
829 RETINAL HAEMORRHAGE 53
830 SCRATCH 53
831 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 52
832 ARTERIOSCLEROSIS 52
833 CAUDA EQUINA SYNDROME 52
834 COLITIS ULCERATIVE 52
835 FREQUENT BOWEL MOVEMENTS 52
836 HYPERVOLAEMIA 52
837 HYPOCALCAEMIA 52
838 JOINT EFFUSION 52
839 NEOPLASM 52
840 NEUTROPHIL COUNT INCREASED 52
841 PERIPHERAL COLDNESS 52
842 PROCEDURAL HYPOTENSION 52
843 RASH GENERALISED 52
844 SPINAL CORD COMPRESSION 52
845 TENDON RUPTURE 52
846 HEPATOMEGALY 51
847 MIDDLE INSOMNIA 51
848 PELVIC PAIN 51
849 RHINITIS 51
850 SECRETION DISCHARGE 51
851 TRICUSPID VALVE INCOMPETENCE 51
852 BEDRIDDEN 50
853 CARDIOVASCULAR DISORDER 50
854 DEAFNESS NEUROSENSORY 50
855 DEVICE BREAKAGE 50
856 FAECES DISCOLOURED 50
857 GINGIVAL BLEEDING 50
858 GROIN PAIN 50
859 HAIR COLOUR CHANGES 50
860 HORDEOLUM 50
861 HYPOALBUMINAEMIA 50
862 INFUSION SITE NODULE 50
863 MUSCLE SPASTICITY 50
864 PSYCHOMOTOR HYPERACTIVITY 50
865 RESPIRATORY ACIDOSIS 50
866 SENSORY DISTURBANCE 50
867 SKIN NECROSIS 50
868 ACUTE PULMONARY OEDEMA 49
869 EXTRAPYRAMIDAL DISORDER 49
870 HEPARIN-INDUCED THROMBOCYTOPENIA 49
871 MACULAR DEGENERATION 49
872 ORAL DISORDER 49
873 PARADOXICAL DRUG REACTION 49
874 RENAL PAIN 49
875 SUBARACHNOID HAEMORRHAGE 49
876 VARICOSE VEIN 49
877 BLOOD ALBUMIN DECREASED 48
878 CEREBRAL INFARCTION 48
879 HYPOTONIA 48
880 INJECTION SITE EXTRAVASATION 48
881 LUMBAR SPINAL STENOSIS 48
882 MELAENA 48
883 MULTIPLE FRACTURES 48
884 MUSCLE ATROPHY 48
885 TOOTH EXTRACTION 48
886 BLOOD MAGNESIUM DECREASED 47
887 EOSINOPHILIA 47
888 FEELING JITTERY 47
889 FLUID OVERLOAD 47
890 FULL BLOOD COUNT ABNORMAL 47
891 HYPERCAPNIA 47
892 IMMUNE SYSTEM DISORDER 47
893 LOW BIRTH WEIGHT BABY 47
894 LUNG NEOPLASM MALIGNANT 47
895 POST-TRAUMATIC STRESS DISORDER 47
896 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 47
897 PURPURA 47
898 RETINAL DETACHMENT 47
899 APHTHOUS ULCER 46
900 CHOLECYSTITIS 46
901 DIVERTICULUM 46
902 DRUG EXPOSURE DURING PREGNANCY 46
903 EYE INFLAMMATION 46
904 HAIR TEXTURE ABNORMAL 46
905 IMMUNE THROMBOCYTOPENIA 46
906 OROPHARYNGEAL DISCOMFORT 46
907 PAIN OF SKIN 46
908 PELVIC FRACTURE 46
909 POISONING 46
910 SCAB 46
911 SKIN FISSURES 46
912 WRONG PRODUCT ADMINISTERED 46
913 ADRENAL INSUFFICIENCY 45
914 ANIMAL BITE 45
915 CHOLECYSTECTOMY 45
916 DRUG-INDUCED LIVER INJURY 45
917 EYE DISCHARGE 45
918 GINGIVITIS 45
919 MYOSITIS 45
920 SKIN WARM 45
921 STAPHYLOCOCCAL SEPSIS 45
922 SYNOVITIS 45
923 THERMAL BURN 45
924 TRANSFUSION 45
925 WALKING AID USER 45
926 ACUTE CORONARY SYNDROME 44
927 ADMINISTRATION SITE PAIN 44
928 ATRIAL FLUTTER 44
929 ATRIOVENTRICULAR BLOCK 44
930 BEHAVIOUR DISORDER 44
931 CENTRAL NERVOUS SYSTEM LESION 44
932 CHOKING 44
933 DIALYSIS 44
934 EXTRASYSTOLES 44
935 IMMUNODEFICIENCY 44
936 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 44
937 LIVER INJURY 44
938 METASTASES TO CENTRAL NERVOUS SYSTEM 44
939 MUSCULOSKELETAL DISORDER 44
940 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 44
941 PROTEINURIA 44
942 PYELONEPHRITIS 44
943 RENAL FAILURE CHRONIC 44
944 RESPIRATION ABNORMAL 44
945 RESPIRATORY RATE INCREASED 44
946 RETINAL VASCULITIS 44
947 RHINITIS ALLERGIC 44
948 THIRST 44
949 ABNORMAL DREAMS 43
950 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 43
951 DELUSION 43
952 DRUG ERUPTION 43
953 FOURNIER^S GANGRENE 43
954 HEPATITIS 43
955 HYPERKERATOSIS 43
956 HYPERTHYROIDISM 43
957 INCREASED TENDENCY TO BRUISE 43
958 INGROWING NAIL 43
959 ISCHAEMIC STROKE 43
960 LAGOPHTHALMOS 43
961 LIVER FUNCTION TEST ABNORMAL 43
962 PNEUMONIA FUNGAL 43
963 PRESCRIBED OVERDOSE 43
964 PRURITUS GENERALISED 43
965 RETINAL ARTERY OCCLUSION 43
966 SKIN HAEMORRHAGE 43
967 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 43
968 SUBDURAL HAEMATOMA 43
969 SUBSTANCE ABUSE 43
970 THINKING ABNORMAL 43
971 ANGER 42
972 BENIGN PROSTATIC HYPERPLASIA 42
973 BLOOD PRESSURE DIASTOLIC DECREASED 42
974 COORDINATION ABNORMAL 42
975 EAR DISCOMFORT 42
976 FAILURE TO THRIVE 42
977 HYDRONEPHROSIS 42
978 HYPERTHERMIA 42
979 IMPAIRED DRIVING ABILITY 42
980 INJECTION SITE DISCHARGE 42
981 PAPULE 42
982 PETECHIAE 42
983 PRODUCT PRESCRIBING ERROR 42
984 RIGHT VENTRICULAR FAILURE 42
985 SPINAL COLUMN STENOSIS 42
986 STRIDOR 42
987 TOTAL LUNG CAPACITY DECREASED 42
988 APPLICATION SITE VESICLES 41
989 BLINDNESS TRANSIENT 41
990 BREAST CANCER METASTATIC 41
991 CATHETER SITE PAIN 41
992 COMPLICATION OF DEVICE INSERTION 41
993 COMPRESSION FRACTURE 41
994 DECREASED ACTIVITY 41
995 DEFORMITY 41
996 DIVERTICULUM INTESTINAL 41
997 ERYTHEMA MULTIFORME 41
998 EYE MOVEMENT DISORDER 41
999 EYELID OEDEMA 41